Home › Asset managers › Compare 2024-2025 › American Century vs ProShares
American Century 2024-2025 · ProShares 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 26,146 | 24,526 | 1,501 | 119 | 94.2% | 94.0% |
| Board proposals | 23,839 | 22,362 | 1,377 | 100 | 94.2% | 94.0% |
| E&S shareholder proposals | 255 | 209 | 38 | 8 | 84.6% | 83.7% |
| Other items | 2,052 | 1,955 | 86 | 11 | 95.8% | 95.6% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,501 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | ProShares |
|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS INC. | June 5, 2025 | Approval of the 2025 Equity Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 11 funds |
| AMKOR TECHNOLOGY INC. | May 15, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 18 funds |
FOR 10 funds |
| AMN HEALTHCARE SERVICES INC. | May 2, 2025 | To approve the AMN Healthcare 2025 Equity Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 11 funds |
| AMNEAL PHARMACEUTICALS INC. | May 6, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 11 funds |
| AMPHENOL CORP. | May 15, 2025 | Advisory vote to approve compensation of named executive officers Shareholder Rights and Defenses |
Board | For | AGAINST 6 funds |
FOR 17 funds |
| ANDERSONS INC. | May 8, 2025 | An advisory vote on executive compensation, approving the resolution provided in the proxy statement. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 12 funds |
| ANGIODYNAMICS INC. | November 12, 2024 | Approval of an amendment to increase the number of shares available for issuance under the AngioDynamics, Inc. 2020 Equity Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 8 funds |
| ANI PHARMACEUTICALS INC. | May 22, 2025 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 14 funds |
| ANI PHARMACEUTICALS INC. | May 22, 2025 | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 14 funds |
| ANIKA THERAPEUTICS INC. | June 20, 2025 | Advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 8 funds |
| ANIKA THERAPEUTICS INC. | June 20, 2025 | Approval of the Amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 8 funds |
| ANNEXON INC. | June 5, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| ANTERIX INC. | August 6, 2024 | To approve Amendment No. 1 to the Anterix Inc. 2023 Stock Plan to increase the number of shares available for issuance under the plan and clarify certain vesting restriction provisions. Compensation |
Board | For | AGAINST 1 fund |
FOR 7 funds |
| ANTERO MIDSTREAM CORP. | June 4, 2025 | To approve, on an advisory basis, the compensation of Antero Midstream Corporation's named executive officers. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 10 funds |
| AON PLC | June 27, 2025 | Advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 17 funds |
| AON PLC | June 27, 2025 | Approve the Aon plc 2011 Incentive Plan, as amended and restated and increase the number of shares available for issuance. Compensation |
Board | For | AGAINST 5 funds |
FOR 17 funds |
| APA CORP. | May 22, 2025 | Advisory Vote to Approve Compensation of APA's Named Executive Officers Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 16 funds |
| APA GROUP | October 24, 2024 | Approve Grant of Performance Rights to Adam Watson Compensation |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| APA GROUP | October 24, 2024 | Elect David Lamont as Director Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| APARTMENT INVESTMENT AND MANAGEMENT CO. | June 10, 2025 | To conduct an advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 8 funds |
| APOGEE ENTERPRISES INC. | June 25, 2025 | Advisory vote to approve Apogee's executive compensation; Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 12 funds |
| APPIAN CORP. | June 4, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| APPLE HOSPITALITY REIT INC. | May 19, 2025 | Approval on an advisory basis of executive compensation paid by the Company. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 13 funds |
| APPLIED OPTOELECTRONICS INC. | June 12, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 8 funds |
| APTARGROUP | May 7, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | Not determined | AGAINST 7 funds |
FOR 10 funds |
| APTARGROUP | May 7, 2025 | Approval of an amendment to the 2018 Equity Incentive Plan. Compensation |
Board | Not determined | AGAINST 6 funds |
FOR 10 funds |
| ARAMARK | January 24, 2025 | To approve, in a non-binding advisory vote, the compensation paid to the named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 7 funds |
| ARCELLX INC. | May 28, 2025 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 11 funds |
| ARCH CAPIT | May 7, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | Not determined | AGAINST 11 funds |
FOR 16 funds |
| ARCOSA INC. | May 14, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 14 funds |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | June 6, 2025 | Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 11 funds |
| ARDENT HEA | May 21, 2025 | Approval, on a non-binding advisory basis, of the compensation of our Named Executive Officers. Say-on-Pay |
Board | Not determined | AGAINST 2 funds |
FOR 4 funds |
| ARGAN INC. | June 17, 2025 | The non-binding advisory approval of our executive compensation (the "say-on-pay" vote). Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 8 funds |
| ARKO CORP. | June 5, 2025 | Approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 8 funds |
| ARQ INC. | June 3, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion as set forth under the Executive Compensation section of the proxy statement for the 2025 Annual Meeting of Stockholders. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 8 funds |
| ARTISAN PARTNERS ASSET MANAGEMENT INC | June 4, 2025 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 13 funds |
| ARTIVION INC. | May 13, 2025 | To approve additional funding of 3,570,000 shares for the Amended and Restated Artivion, Inc. 2020 Equity and Cash Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 11 funds |
| ARTIVION INC. | May 13, 2025 | To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 11 funds |
| ARVINAS INC. | June 25, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 11 funds |
| ASSOCIATED | April 29, 2025 | Approval of the Associated Banc-Corp 2025 Equity Incentive Plan. Compensation |
Board | Not determined | AGAINST 5 funds |
FOR 18 funds |
| ASTEC INDUSTRIES INC. | April 25, 2025 | to approve the Astec Industries, Inc. 2025 Equity Incentive Plan; and Compensation |
Board | For | AGAINST 7 funds |
FOR 11 funds |
| ASTRANA HEALTH INC. | June 11, 2025 | To approve the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 11 funds |
| ASTRONICS CORP. | May 22, 2025 | To approve an amendment of the Amended and Restated 2017 Long Term Incentive Plan (the "2017 LTIP") to increase the number of shares available for issuance under the 2017 LTIP. Compensation |
Board | For | AGAINST 2 funds |
FOR 8 funds |
| AT&T | May 15, 2025 | Advisory Approval of Executive Compensation Say-on-Pay |
Board | Not determined | AGAINST 10 funds |
FOR 17 funds |
| ATEA PHARMACEUTICALS INC. | June 20, 2025 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| ATLANTIC U | May 6, 2025 | To approve the Atlantic Union Bankshares Corporation 2025 Stock and Incentive Plan Compensation |
Board | Not determined | AGAINST 7 funds |
FOR 14 funds |
| ATLASSIAN CORP PLC | December 11, 2024 | An advisory vote to approve the compensation of our named executive officers for the fiscal year ended June 30, 2024. Say-on-Pay |
Board | Not determined | AGAINST 8 funds |
FOR 10 funds |
| ATMOS ENERGY CORP. | February 5, 2025 | Proposal to approve an amendment to the Company's 1998 Long - Term Incentive Plan to provide for an increase of 2,000,000 shares of common stock reserved for issuance under the plan. Compensation |
Board | For | AGAINST 13 funds |
FOR 19 funds |
| ATRICURE INC. | May 19, 2025 | Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,700,000. Compensation |
Board | For | AGAINST 1 fund |
FOR 8 funds |
| AURINIA PHARMACEUTICALS INC. | May 15, 2025 | Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| AURINIA PHARMACEUTICALS INC. | May 15, 2025 | Amendment to Equity Incentive Plan To approve the amendment to the Company's Equity Incentive Plan to increase the maximum number of common shares of the Company reserved for issuance pursuant to the Equity Incentive Plan, as set forth in the Company's Proxy Statement/Circular. Compensation |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| AURIZON HOLDINGS LTD. | October 10, 2024 | Approve Grant of Performance Rights to Andrew Harding Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| AUTODESK | June 18, 2025 | Amend and restate the 2022 Equity Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 24 funds |
| AUTODESK INC. | June 18, 2025 | Approve, on an advisory (non-binding) basis, the compensation of Autodesk, Inc's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 24 funds |
| AUTOLIV INC. | May 8, 2025 | Advisory vote on Autoliv, Inc.'s 2024 Executive Compensation. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 7 funds |
| AVEANNA HEALTHCARE HOLDINGS INC. | May 9, 2025 | To approve, on an advisory, non-binding basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 8 funds |
| AVEPOINT INC. | May 6, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| AVID BIOSERVICES INC. | October 16, 2024 | To approve an amendment to the Company's 2018 Omnibus Incentive Plan to increase the number of shares reserved thereunder. Compensation |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| AVIENT COR | May 14, 2025 | Approval, on an advisory basis, of Named Executive Officer compensation. Say-on-Pay |
Board | Not determined | AGAINST 11 funds |
FOR 16 funds |
| AVIS BUDGET GROUP INC. | May 14, 2025 | Advisory approval of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 7 funds |
| AVISTA CORP. | May 8, 2025 | Advisory (non-binding) vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| AXCELIS TECHNOLOGIES INC. | May 7, 2025 | Proposal to amend the 2012 Equity Incentive Plan to increase the number of shares reserve for issuance Compensation |
Board | For | AGAINST 8 funds |
FOR 17 funds |
| AXCELIS TECHNOLOGIES INC. | May 7, 2025 | Say on Pay - An advisory vote on the approval of executive compensation Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 17 funds |
| AXOGEN INC. | June 18, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 8 funds |
| AXON ENTERPRISE INC. | May 29, 2025 | Proposal No. 2 requests that shareholders vote to approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 24 funds |
| AXOS FINANCIAL INC. | November 14, 2024 | To approve in a non-binding and advisory vote, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 15 funds |
| AZEK COMPANY INC. | June 27, 2025 | A proposal to approve, by advisory (non-binding) vote, certain compensation arrangements that may be paid or become payable to AZEK's named executive officers in connection with the transactions contemplated by the merger agreement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| B&G FOODS INC. | May 15, 2025 | Approval, by non-binding advisory vote, of executive compensation: Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 11 funds |
| BAKER HUGH | May 20, 2025 | An advisory vote related to the Company's executive compensation program Say-on-Pay |
Board | Not determined | AGAINST 19 funds |
FOR 23 funds |
| BANCFIRST CORP. | May 22, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 13 funds |
| BANK FIRST CORP. | June 16, 2025 | To approve the compensation of the Company's named executive officers through an advisory vote; Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 8 funds |
| BANK OF HAWAII CORP. | April 25, 2025 | Approval of the Bank of Hawai'i Corporation 2025 Director Stock Compensation Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 15 funds |
| BANK OF MARIN BANCORP | May 21, 2025 | To approve, by non-binding vote, executive compensation Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 8 funds |
| BANK7 CORP. | May 15, 2025 | Advisory vote on named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 8 funds |
| BANKUNITED INC. | May 22, 2025 | Advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 15 funds |
| BANNER CORP. | May 22, 2025 | Advisory approval of the compensation of Banner Corporation's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 15 funds |
| BAR HARBOR BANKSHARES | May 15, 2025 | To hold a non-binding advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 8 funds |
| BARRETT BUSINESS SERVICES INC. | June 2, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 8 funds |
| BAYCOM CORP | June 17, 2025 | An advisory (non-binding) vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 8 funds |
| BECTON, DICKINSON AND CO. | January 28, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 15 funds |
FOR 18 funds |
| BEL FUSE INC. | May 27, 2025 | With respect to the approval, on an advisory basis, of the executive compensation of Bel's named executive officers as described in the Proxy Statement Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 8 funds |
| BENCHMARK ELECTRONICS INC. | May 14, 2025 | To provide an advisory vote on the compensation of the Company's named executive officers; Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 13 funds |
| BERKSHIRE HILLS BANCORP INC. | May 21, 2025 | A proposal to approve the Berkshire Hills Bancorp, Inc. 2025 Stock Option and Incentive Plan (the "Berkshire Equity Plan Proposal"). Compensation |
Board | For | AGAINST 7 funds |
FOR 11 funds |
| BERRY GLOB | February 5, 2025 | To approve, on an advisory, non-binding basis, our executive compensation. Say-on-Pay |
Board | Not determined | AGAINST 6 funds |
FOR 8 funds |
| BEST BUY CO. INC. | June 13, 2025 | To approve Amendment No. 1 to our 2020 Omnibus Incentive Plan Compensation |
Board | For | AGAINST 9 funds |
FOR 17 funds |
| BHP GROUP LTD. | October 30, 2024 | Approve Grant of Awards to Mike Henry Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| BHP GROUP LTD. | October 30, 2024 | Approve Grant of Awards to Mike Henry Compensation |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| BIO-TECHNE CORP | October 24, 2024 | Approve, on an advisory basis, the compensation of our executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 16 funds |
| BIOCRYST PHARMACEUTICALS INC. | June 12, 2025 | To hold a non-binding, advisory vote regarding executive compensation. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 11 funds |
| BIOHAVEN LTD | May 5, 2025 | A non-binding advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 10 funds |
| BIOMARIN PHARMACEUTICAL INC. | May 20, 2025 | To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. Compensation |
Board | For | AGAINST 11 funds |
FOR 10 funds |
| BIT DIGITAL INC. | May 20, 2025 | Approval for the Company to adopt the Company's 2025 Omnibus Equity Incentive Plan "It is resolved as an Ordinary Resolution that shareholders of the Company hereby approve the 2025 Omnibus Equity Incentive Plan." Compensation |
Board | For | AGAINST 2 funds |
FOR 8 funds |
| BLACKBAUD INC. | June 11, 2025 | ADVISORY VOTE TO APPROVE THE 2024 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 19 funds |
| BLACKLINE INC. | May 8, 2025 | Approval, on a non-binding, advisory basis, of the 2024 compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 13 funds |
| BLOOMIN' BRANDS INC. | April 23, 2025 | To approve the Bloomin' Brands, Inc. 2025 Omnibus Incentive Compensation Plan Compensation |
Board | For | AGAINST 9 funds |
FOR 11 funds |
| BLOOMIN' BRANDS INC. | April 23, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 11 funds |
| BLUELINX HOLDINGS INC | May 15, 2025 | Proposal to approve the non-binding, advisory resolution regarding the executive compensation described in the proxy statement. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 8 funds |
| BLUEPRINT MEDICINES CORP. | June 18, 2025 | Approval of a non-binding advisory vote on the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 11 funds |
| BOISE CASCADE CO. | May 1, 2025 | Approval of the 2025 Boise Cascade Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 11 funds |
| BOK FINANC | April 29, 2025 | Advisory approval of the compensation of the Company's named executive officers disclosed in the Proxy Statement. Say-on-Pay |
Board | Not determined | AGAINST 8 funds |
FOR 2 funds |
← Previous Page 3 of 16 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.